{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:37:08Z","timestamp":1778924228035,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013228","name":"Granskingarr\u00e1\u00f0i\u00f0","doi-asserted-by":"publisher","award":["0334"],"award-info":[{"award-number":["0334"]}],"id":[{"id":"10.13039\/501100013228","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jacl.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T10:23:40Z","timestamp":1687688620000},"page":"633-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Possible explanations for the common clinical familial hypercholesterolemia phenotypes in the Faroe Islands"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0078-8040","authenticated-orcid":false,"given":"Sanna \u00e1","family":"Borg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-9511","authenticated-orcid":false,"given":"Albert Marni","family":"Joensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Ren\u00e9 Skjelbo","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1sa Wraae","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab Bishara Yousef","family":"Lolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Okkels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Lundbye-Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Berg","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian S\u00f8rensen","family":"Bork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2023.06.003_bib0001","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jacl.2023.06.003_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-017-0848-8","article-title":"Genetic architecture of familial hypercholesterolaemia","volume":"19","author":"Sharifi","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.jacl.2023.06.003_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2023.06.003_bib0004","first-page":"111","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jacl.2023.06.003_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.jacl.2023.06.003_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00439-004-1117-7","article-title":"The origin of the isolated population of the Faroe islands investigated using Y chromosomal markers","volume":"115","author":"Jorgensen","year":"2004","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.jacl.2023.06.003_bib0007","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.ejhg.5201578","article-title":"Highly discrepant proportions of female and male Scandinavian and British Isles ancestry within the isolated population of the Faroe Islands","volume":"14","author":"Als","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.jacl.2023.06.003_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10545-013-9606-2","article-title":"Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands","volume":"37","author":"Rasmussen","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"10.1016\/j.jacl.2023.06.003_bib0009","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ecco-jcc\/jjw050","article-title":"The Faroese IBD study: incidence of inflammatory bowel diseases across 54 years of population-based data","volume":"10","author":"Hammer","year":"2016","journal-title":"J Crohn's Colitis"},{"issue":"2","key":"10.1016\/j.jacl.2023.06.003_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/acn3.51501","article-title":"High incidence of amyotrophic lateral sclerosis in the Faroe Islands 2010\u20132020","volume":"9","author":"Johansen","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.jacl.2023.06.003_bib0011","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/sj.ejhg.5200632","article-title":"Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands","volume":"9","author":"Santer","year":"2001","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.jacl.2023.06.003_bib0012","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/brain\/awl389","article-title":"SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness","volume":"130","author":"Carrozzo","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jacl.2023.06.003_bib0013","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.atherosclerosis.2021.06.143","article-title":"The Faroe Islands - a possible founder population with a very high prevalence of familial hypercholesterolemia","volume":"331","author":"Borg","year":"2021","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2023.06.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050857","article-title":"Familial hypercholesterolaemia: a study protocol for identification and investigation of potential causes and markers of subclinical coronary artery disease in the Faroe Islands","volume":"12","author":"Borg","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jacl.2023.06.003_bib0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"issue":"6807","key":"10.1016\/j.jacl.2023.06.003_bib0016","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Betteridge","year":"1991","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.jacl.2023.06.003_bib0017","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"10.1016\/j.jacl.2023.06.003_bib0018","first-page":"1","article-title":"Validation of the heartdiet questionnaire","volume":"65","author":"Laursen","year":"2018","journal-title":"Dan Med J"},{"issue":"1","key":"10.1016\/j.jacl.2023.06.003_bib0019","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2023.06.003_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.atherosclerosis.2018.06.006","article-title":"Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia","volume":"277","author":"Futema","year":"2018","journal-title":"Atherosclerosis"},{"issue":"9874","key":"10.1016\/j.jacl.2023.06.003_bib0021","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacl.2023.06.003_bib0022","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ajcn\/42.2.317","article-title":"Rapids sampling and long-term storage of subcutaneous adipose-tissue biopsies for determination of fatty acid composition","volume":"42","author":"Beynen","year":"1985","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.jacl.2023.06.003_bib0023","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/CIRCULATIONAHA.110.987057","article-title":"Marine n-3 polyunsaturated fatty acids in adipose tissue and the risk of acute coronary syndrome","volume":"124","author":"Joensen","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacl.2023.06.003_bib0024","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1373\/clinchem.2019.306738","article-title":"Effect of lipoprotein(a) on the diagnosis of familial hypercholesterolemia: does it make a difference in the clinic?","volume":"65","author":"Chan","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2023.06.003_bib0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.jacl.2023.06.003_bib0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.athplu.2022.03.004","article-title":"Lipids, lipoproteins and prevalence of familial hypercholesterolemia in the Faroe Islands \u2013 results from a nationwide laboratory database","volume":"48","author":"Borg","year":"2022","journal-title":"Atheroscler Plus"},{"issue":"5","key":"10.1016\/j.jacl.2023.06.003_bib0027","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00219339","article-title":"Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians","volume":"88","author":"B\u00e9tard","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacl.2023.06.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1007\/BF00284709","article-title":"Familial hypercholesterolemia in South African Afrikaners Pvull and Stul DNA polymorphisms in the LDL-receptor gene consistent with a predominating founder gene effect","volume":"77","author":"Brink","year":"1987","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacl.2023.06.003_bib0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/07853890108995954","article-title":"Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences","volume":"33","author":"Vuorio","year":"2001","journal-title":"Ann. Med"},{"issue":"1","key":"10.1016\/j.jacl.2023.06.003_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1098-1004(1997)10:1<36::AID-HUMU5>3.0.CO;2-K","article-title":"Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population","volume":"10","author":"Gudnason","year":"1997","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.jacl.2023.06.003_bib0031","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacl.2023.06.003_bib0032","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2023.06.003_bib0033","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2017.05.015","article-title":"Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia","volume":"263","author":"Sharifi","year":"2017","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.jacl.2023.06.003_bib0034","first-page":"18932","article-title":"Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events","volume":"10","author":"D'erasmo","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2023.06.003_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOL.0000000000000737","article-title":"Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance","volume":"32","author":"Trinder","year":"2021","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2023.06.003_bib0036","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.jacl.2023.06.003_bib0037","first-page":"1689","article-title":"Estimation of the concentration of low-density lipoprotein cholesterolin plasma,without use of the preparative ultracentrifuge","volume":"53","author":"Friedewald","year":"1972","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jacl.2023.06.003_bib0038","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2213-8587(16)30082-1","article-title":"Familial hypercholesterolaemia: beware of lipoprotein(a)","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diab Endocrinol"},{"issue":"19","key":"10.1016\/j.jacl.2023.06.003_bib0039","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jacl.2023.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1494-9","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jacl.2023.06.003_bib0041","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"25","key":"10.1016\/j.jacl.2023.06.003_bib0042","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2023.06.003_bib0043","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.ejcn.1602973","article-title":"Health effects of trans-fatty acids: experimental and observational evidence","volume":"63","author":"Mozaffarian","year":"2009","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jacl.2023.06.003_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000252","article-title":"Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Mozaffarian","year":"2010","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.jacl.2023.06.003_bib0045","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.numecd.2017.10.010","article-title":"A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease","volume":"27","author":"Clifton","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2023.06.003_bib0046","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","article-title":"Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake","volume":"47","author":"Hodson","year":"2008","journal-title":"Progr Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:17:42Z","timestamp":1778833062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423002131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1933287423002131"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.06.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible explanations for the common clinical familial hypercholesterolemia phenotypes in the Faroe Islands","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}